Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast | 15 | 2024 | 1976 | 1.840 |
Why?
|
Breast Neoplasms | 32 | 2024 | 21207 | 1.430 |
Why?
|
Breast Diseases | 4 | 2021 | 442 | 1.320 |
Why?
|
Body Fluids | 6 | 2013 | 321 | 1.120 |
Why?
|
Labor, Obstetric | 5 | 2016 | 323 | 1.100 |
Why?
|
Testosterone | 4 | 2024 | 2491 | 0.930 |
Why?
|
Premature Birth | 6 | 2020 | 1829 | 0.830 |
Why?
|
Obstetric Labor, Premature | 2 | 2014 | 268 | 0.820 |
Why?
|
Cervix Uteri | 5 | 2013 | 577 | 0.790 |
Why?
|
Infectious Mononucleosis | 1 | 2022 | 133 | 0.760 |
Why?
|
Vagina | 6 | 2013 | 850 | 0.760 |
Why?
|
Nipples | 1 | 2023 | 227 | 0.730 |
Why?
|
Mammary Glands, Human | 1 | 2021 | 202 | 0.670 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2013 | 299 | 0.660 |
Why?
|
Labor Onset | 3 | 2010 | 17 | 0.510 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.500 |
Why?
|
Abortion, Threatened | 1 | 2014 | 4 | 0.470 |
Why?
|
Retinal Dehydrogenase | 2 | 2024 | 78 | 0.460 |
Why?
|
Mammography | 2 | 2024 | 2433 | 0.460 |
Why?
|
Term Birth | 5 | 2014 | 140 | 0.440 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.420 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 88 | 0.420 |
Why?
|
Blood Cells | 1 | 2014 | 309 | 0.400 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2011 | 72 | 0.380 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2011 | 60 | 0.380 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2013 | 137 | 0.380 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 150 | 0.370 |
Why?
|
Cystatin A | 1 | 2010 | 6 | 0.370 |
Why?
|
Serum Albumin | 1 | 2014 | 677 | 0.370 |
Why?
|
Cysteine Proteases | 1 | 2010 | 13 | 0.370 |
Why?
|
Cervix Mucus | 1 | 2010 | 18 | 0.360 |
Why?
|
Body Mass Index | 5 | 2024 | 13053 | 0.360 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2011 | 133 | 0.350 |
Why?
|
Postmenopause | 2 | 2019 | 2518 | 0.350 |
Why?
|
Diterpenes | 1 | 2011 | 170 | 0.340 |
Why?
|
Gene Expression | 4 | 2020 | 7601 | 0.340 |
Why?
|
Capsaicin | 1 | 2011 | 235 | 0.340 |
Why?
|
Cathepsins | 1 | 2010 | 243 | 0.340 |
Why?
|
Substance P | 1 | 2011 | 332 | 0.330 |
Why?
|
Menarche | 2 | 2024 | 538 | 0.330 |
Why?
|
TRPV Cation Channels | 1 | 2011 | 244 | 0.320 |
Why?
|
Health Surveys | 1 | 2018 | 4057 | 0.310 |
Why?
|
Pregnancy | 15 | 2020 | 30255 | 0.300 |
Why?
|
Female | 54 | 2024 | 397187 | 0.300 |
Why?
|
Nurses | 3 | 2022 | 2501 | 0.280 |
Why?
|
Interleukin-1beta | 1 | 2013 | 1028 | 0.280 |
Why?
|
Receptors, Estrogen | 6 | 2022 | 2253 | 0.270 |
Why?
|
Adult | 32 | 2024 | 223646 | 0.250 |
Why?
|
Epidemiology | 2 | 2019 | 278 | 0.250 |
Why?
|
Proteomics | 4 | 2024 | 3912 | 0.250 |
Why?
|
Vaginal Smears | 1 | 2008 | 505 | 0.250 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3610 | 0.240 |
Why?
|
Pathology, Molecular | 2 | 2019 | 329 | 0.240 |
Why?
|
Databases, Genetic | 4 | 2020 | 1758 | 0.240 |
Why?
|
Urinary Bladder | 1 | 2011 | 1157 | 0.230 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3187 | 0.230 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9540 | 0.220 |
Why?
|
Sex Reassignment Procedures | 1 | 2024 | 72 | 0.220 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.210 |
Why?
|
MicroRNAs | 3 | 2024 | 3803 | 0.210 |
Why?
|
Humans | 56 | 2024 | 768171 | 0.210 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4282 | 0.210 |
Why?
|
Spinal Cord | 1 | 2011 | 1812 | 0.210 |
Why?
|
Receptors, Androgen | 2 | 2019 | 1089 | 0.200 |
Why?
|
Parity | 2 | 2021 | 931 | 0.200 |
Why?
|
Antioxidants | 1 | 2010 | 1676 | 0.200 |
Why?
|
Trans-Activators | 3 | 2020 | 2857 | 0.200 |
Why?
|
Middle Aged | 23 | 2024 | 223487 | 0.200 |
Why?
|
Analysis of Variance | 3 | 2021 | 6229 | 0.190 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 954 | 0.180 |
Why?
|
Risk Factors | 15 | 2024 | 74944 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3814 | 0.180 |
Why?
|
Gestational Age | 4 | 2020 | 3621 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 630 | 0.180 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 70 | 0.170 |
Why?
|
Reproductive History | 1 | 2021 | 210 | 0.170 |
Why?
|
Hyperplasia | 1 | 2023 | 1151 | 0.170 |
Why?
|
Neck | 1 | 2024 | 736 | 0.160 |
Why?
|
Radon | 1 | 2020 | 91 | 0.160 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 438 | 0.160 |
Why?
|
Elasticity | 1 | 2021 | 657 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 9016 | 0.150 |
Why?
|
Alcohol Drinking | 3 | 2023 | 4045 | 0.150 |
Why?
|
Body Size | 1 | 2021 | 463 | 0.150 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 165 | 0.140 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 2972 | 0.140 |
Why?
|
RNA, Messenger | 3 | 2020 | 12801 | 0.140 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 123 | 0.140 |
Why?
|
Automation | 1 | 2019 | 589 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 356 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1105 | 0.140 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 273 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15453 | 0.130 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11930 | 0.130 |
Why?
|
Risk Assessment | 5 | 2021 | 24318 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1082 | 0.130 |
Why?
|
Lymphatic Metastasis | 1 | 2024 | 2914 | 0.130 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1422 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 410 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2019 | 480 | 0.120 |
Why?
|
Proteins | 1 | 2010 | 6009 | 0.120 |
Why?
|
Western Australia | 1 | 2014 | 41 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6525 | 0.120 |
Why?
|
Genomics | 3 | 2022 | 5926 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2021 | 22290 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1565 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1524 | 0.110 |
Why?
|
Adiposity | 2 | 2021 | 1895 | 0.110 |
Why?
|
Prognosis | 8 | 2024 | 30009 | 0.110 |
Why?
|
Liver Cirrhosis | 1 | 2024 | 1960 | 0.110 |
Why?
|
Aldehyde Dehydrogenase | 2 | 2024 | 146 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 934 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3620 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20225 | 0.110 |
Why?
|
Menopause | 1 | 2021 | 1656 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3445 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2024 | 3474 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1812 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1643 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1793 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.090 |
Why?
|
Demography | 1 | 2016 | 1641 | 0.090 |
Why?
|
Unsafe Sex | 1 | 2013 | 239 | 0.090 |
Why?
|
Estradiol | 1 | 2018 | 1951 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2048 | 0.090 |
Why?
|
Time Factors | 5 | 2014 | 40220 | 0.090 |
Why?
|
Biopsy | 4 | 2024 | 6792 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.090 |
Why?
|
Proteome | 2 | 2013 | 1890 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2360 | 0.090 |
Why?
|
Fibronectins | 1 | 2014 | 722 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2020 | 3806 | 0.090 |
Why?
|
Computational Biology | 2 | 2020 | 3567 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 23648 | 0.080 |
Why?
|
Amniotic Fluid | 1 | 2011 | 381 | 0.080 |
Why?
|
Thioredoxins | 1 | 2010 | 202 | 0.080 |
Why?
|
Sacrum | 1 | 2011 | 274 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9613 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2862 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 942 | 0.080 |
Why?
|
Phthalazines | 2 | 2022 | 397 | 0.080 |
Why?
|
Environmental Exposure | 2 | 2020 | 4543 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2931 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9419 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 1 | 2011 | 468 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3390 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 596 | 0.070 |
Why?
|
Anthropometry | 2 | 2024 | 1346 | 0.070 |
Why?
|
Cohort Studies | 4 | 2024 | 41753 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2202 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13290 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 751 | 0.070 |
Why?
|
Labor, Induced | 1 | 2008 | 156 | 0.070 |
Why?
|
Rats, Wistar | 1 | 2011 | 1890 | 0.070 |
Why?
|
Mitosis | 2 | 2024 | 1178 | 0.070 |
Why?
|
Aged | 6 | 2024 | 171502 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3311 | 0.070 |
Why?
|
Models, Genetic | 1 | 2016 | 3447 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2374 | 0.070 |
Why?
|
Air Pollutants | 1 | 2020 | 2916 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4413 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8743 | 0.060 |
Why?
|
Maternal Age | 1 | 2008 | 805 | 0.060 |
Why?
|
Male | 8 | 2024 | 364731 | 0.060 |
Why?
|
Receptors, Progesterone | 2 | 2020 | 1160 | 0.060 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2227 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2024 | 81760 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2020 | 26421 | 0.050 |
Why?
|
Giant Cells | 1 | 2023 | 187 | 0.050 |
Why?
|
Phenotype | 2 | 2022 | 16726 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2479 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12077 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4916 | 0.050 |
Why?
|
Birth Weight | 1 | 2011 | 2121 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 18065 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12795 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2885 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 579 | 0.050 |
Why?
|
Age Factors | 3 | 2024 | 18415 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 340 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14783 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 422 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 506 | 0.050 |
Why?
|
Adolescent | 4 | 2022 | 89169 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2011 | 1886 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7876 | 0.050 |
Why?
|
Stem Cells | 2 | 2024 | 3538 | 0.050 |
Why?
|
Regression Analysis | 1 | 2010 | 6340 | 0.040 |
Why?
|
Alberta | 1 | 2020 | 67 | 0.040 |
Why?
|
Niacinamide | 1 | 2022 | 418 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3948 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8648 | 0.040 |
Why?
|
Mastectomy | 2 | 2019 | 1862 | 0.040 |
Why?
|
Obesity | 2 | 2021 | 13091 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 60066 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2021 | 551 | 0.040 |
Why?
|
Cesarean Section | 1 | 2008 | 1425 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2010 | 3140 | 0.040 |
Why?
|
Child | 3 | 2022 | 80917 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 11 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14164 | 0.040 |
Why?
|
Premenopause | 1 | 2023 | 1039 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 30237 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10763 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2019 | 151 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 57 | 0.040 |
Why?
|
NAD | 1 | 2022 | 618 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 905 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 587 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1120 | 0.030 |
Why?
|
Epithelium | 1 | 2021 | 1607 | 0.030 |
Why?
|
Morpholines | 1 | 2019 | 584 | 0.030 |
Why?
|
Pathology | 1 | 2019 | 270 | 0.030 |
Why?
|
Cell Cycle | 1 | 2024 | 2934 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7452 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 580 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1337 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 519 | 0.030 |
Why?
|
Rats | 1 | 2011 | 23782 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 753 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2152 | 0.030 |
Why?
|
Tamoxifen | 1 | 2019 | 966 | 0.030 |
Why?
|
Animals | 5 | 2024 | 169285 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 17142 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 581 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2956 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14729 | 0.030 |
Why?
|
Phosphorylation | 1 | 2024 | 8316 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2065 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 162 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1625 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2981 | 0.020 |
Why?
|
Neoplasms | 2 | 2019 | 22371 | 0.020 |
Why?
|
Mice | 3 | 2024 | 82049 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54924 | 0.020 |
Why?
|
Cell Division | 1 | 2018 | 4477 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3556 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26379 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2603 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6231 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3334 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2554 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4648 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 2982 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6847 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2617 | 0.020 |
Why?
|
Specimen Handling | 1 | 2013 | 707 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2535 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5802 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4913 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5797 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 917 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2008 | 399 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5213 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3703 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22380 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9561 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12543 | 0.010 |
Why?
|
Diet | 1 | 2022 | 8089 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9374 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10478 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39354 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11878 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42669 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13422 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17623 | 0.010 |
Why?
|